Loading stock data…
NeuroOne Medical Technologies C (NMTC)
$3.34
Market ClosedLast close Jun 29
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NeuroOne Medical Technologies Corporation in the Healthcare sector is trading at $3.34 with a market capitalization of $29M. Wall Street consensus targets $9.93 (3 analysts), implying a +197.4% move over the next 12 months. The stock is currently near its 52-week low of $3.08, remaining 26.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +197.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.39M↓ | $2.89M↑ | $2.74M↑ | $1.70M↑ | $1.39M |
| Gross Profit | $1.29M↓ | $1.57M↑ | $1.53M↑ | $914,835↑ | $771,061 |
| Operating Income | -$2.10M↓ | -$1.71M↓ | -$1.37M↑ | -$1.89M↑ | -$2.68M |
| Net Income | -$2.09M↓ | -$1.44M↑ | -$1.62M↓ | -$1.50M↑ | -$2.27M |
Peer Comparison
JNJUNHPFE
Fundamentals
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for sp...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$29.22M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.51
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-123.63%
Volume
Today's trading volume
10,516
Recent News
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Highlights: Strong Product ...
NeuroOne Medical Technologies Corp (NMTC) reports significant revenue growth and strategic advancements, despite facing profitability and cash flow challenges.
NeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
Despite a dip in revenue, NeuroOne Medical Technologies Corp (NMTC) showcases promising advancements and strategic partnerships for future growth.
NeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary
Moby summary of NeuroOne Medical Technologies Corporation's Q1 2026 earnings call
New Strong Buy Stocks for January 6th
ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th, 2026.
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ...
NeuroOne Medical Technologies Corp (NMTC) reports significant revenue growth, improved margins, and strategic progress despite challenges in compliance and international expansion.